Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Cipher Pharmaceuticals Inc.
ClinicalTrials.gov Identifier:
NCT00975143
First received: September 9, 2009
Last updated: June 4, 2012
Last verified: June 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2011
  Primary Completion Date: May 2011 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: May 30, 2012